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Animal studies demonstrate that noise exposure can permanently damage the synapses between 41 
inner hair cells and auditory nerve fibers, even when outer hair cells are intact and there is no 42 
clinically relevant permanent threshold shift. Synaptopathy disrupts the afferent connection 43 
between the cochlea and the central auditory system and is predicted to impair speech 44 
understanding in noisy environments and potentially result in tinnitus and/or hyperacusis. While 45 
cochlear synaptopathy has been demonstrated in numerous experimental animal models, 46 
synaptopathy can only be confirmed through post-mortem temporal bone analysis, making it 47 
difficult to study in living humans. A variety of non-invasive measures have been used to 48 
determine whether noise-induced synaptopathy occurs in humans, but the results are conflicting. 49 
The overall objective of this article is to synthesize the existing data on the functional impact of 50 
noise-induced synaptopathy in the human auditory system. The first section of the article 51 
summarizes the studies that provide evidence for and against noise-induced synaptopathy in 52 
humans. The second section offers potential explanations for the differing results between 53 
studies. The final section outlines suggested methodologies for diagnosing synaptopathy in 54 
humans with the aim of improving consistency across studies.  55 
  56 
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Introduction   57 
Damage to the inner ear, and associated hearing loss, occurs from noise trauma, ototoxic drugs, 58 
aging and genetic factors. One form of cochlear pathology involves synaptic damage that perturbs 59 
the neurotransmission between the inner hair cell (IHC) and auditory nerve (AN) fibers. This type 60 
of pathology has been termed cochlear synaptopathy (Kujawa and Liberman, 2015) and popularly 61 
“hidden hearing loss” (Schaette and McAlpine, 2011) because it can occur without affecting 62 
hearing thresholds. However, the definition of the latter term has become inconsistent between 63 
articles, with some authors using it to refer more generally to hearing dysfunction in the presence 64 
of normal hearing thresholds. For this reason, we will avoid use of the term “hidden hearing loss” 65 
in the present review. The predicted functional consequences of these synaptic alterations are 66 
listening difficulties in noisy backgrounds, tinnitus and hyperacusis (Kujawa & Liberman 2015). 67 
Experimental work, primarily on noise-traumatized and ageing rodents, has clearly demonstrated 68 
that the afferent synapse is more vulnerable than hair cells. AN fibers with low and medium 69 
spontaneous rates (SRs) and higher response thresholds appear to be particularly vulnerable to 70 
noise damage (Furman et al. 2013). Since these fibers do not respond at low intensity levels, their 71 
loss does not impact measures of auditory threshold, such as the clinical audiogram. Although 72 
auditory brainstem response (ABR) thresholds are insensitive to these synaptic changes, and there 73 
is some evidence that low SR-fibers do not contribute to the amplitude of ABR wave 1 (Bourien et 74 
al., 2014), the amplitude of ABR wave 1 recorded to supra-threshold transients appears to be a 75 
sensitive indicator of synaptopathy (Kujawa and Liberman, 2015; Furman et al., 2013). The 76 
amplitude of the middle-ear muscle reflex (MEMR) and the envelope following response (EFR) 77 
also appear to be sensitive to synaptopathy in animal models (Shaheen et al. 2015; Valero et al. 78 
2016; Valero et al. 2018).  An alternative explanation is that the low spontaneous fibers are more 79 
involved in efferent regulation than in high-intensity coding (Carney, 2018). 80 
It has recently been questioned whether cochlear synaptopathy occurs in humans and if 81 
there is evidence for functional consequences of this phenomenon, as revealed by listening 82 
difficulties in noisy backgrounds, tinnitus or hyperacusis. The purpose of this article is to highlight 83 
the research that finds evidence supporting noise-induced human synaptopathy, contrast this with 84 
studies that have not provided supporting evidence, discuss possible reasons for null results and 85 
diverging outcomes, and provide guidance to the field regarding research protocols. To outline 86 
these inconsistencies, the existing data that either support or do not support that noise-induced 87 
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synaptopathy occurs in humans are summarized. Details of the cited studies can be found in Table 88 
1. Next, possible explanations for these inconsistencies are provided. Finally, the last part of the 89 
article discusses methodological considerations for diagnosing synaptopathy in humans in order to 90 
standardize future experimental approaches. This will facilitate the integration of data across 91 
studies and improve the overall understanding of cochlear synaptopathy in humans.  92 
 93 
 94 
Data Consistent with Noise-Induced Synaptopathy in Humans  95 
Post-mortem temporal bone studies  96 
There is little debate regarding the existence of age-related synaptic loss (or synaptopathy) in the 97 
human inner ear. Analysis of temporal bones harvested post-mortem demonstrate that both age-98 
related synaptopathy (Viana et al. 2015) (Figure 1) and age-related neural degeneration can occur 99 
in humans (Makary et al. 2011). In the study by Makary et al., temporal bones were carefully 100 
selected to include only those with no overt loss of either IHCs or outer hair cells (OHCs), 101 
demonstrating that spiral ganglion cell numbers can decrease prior to hair cell loss. The results of 102 
Viana et al. suggest that synaptopathy can also occur independently of hair cell loss. The same 103 
study also included temporal bones with a combination of synaptic loss and hair cell (IHC and 104 
OHC) loss, with the most extreme hair cell loss observed in the cochlear base. Interestingly, a 105 
temporal bone from a female (age 67) donor had a notched OHC loss centered at 3000 Hz, which 106 
is suggestive of previous noise injury. Fewer type I fibers/IHC and fewer synapses/IHC were 107 
observed in this donor relative to a 54-year-old male and a 70-year-old female donors, which is 108 
consistent with noise-related neuronal/synaptic loss. These findings build on earlier observations 109 
of age-related AN fiber loss in temporal bones that also had “expected” age-related loss of OHCs 110 
(Felder & Schrott-Fischer 1995). Wu et al. (2018) also demonstrated significant age-related 111 
synapse and AN fiber loss in ears with expected age-related loss of hair cells. In addition, although 112 
spiral ganglion cell loss can occur independently of hair cell loss, neuronal loss is greater when 113 
hair cells are also missing (Otte et al. 1978). Thus, cochlear synaptopathy and neuropathy may be 114 
some of the earliest manifestations of future sensorineural hearing loss (SNHL) where 115 




Human auditory brainstem response studies of noise-induced synaptopathy 118 
To date, the electrophysiological metric for studying synaptopathy in humans has been the 119 
amplitude of wave I of the ABR, a measure of AN function that is associated with synaptopathy in 120 
rodent models (Kujawa & Liberman 2009; Sergeyenko et al. 2013). In a sample of young (age 19-121 
35) military Veterans and non-Veterans with normal audiograms and good distortion-product 122 
otoacoustic emissions (DPOAEs), Bramhall et al. (2017) found a reduction in ABR wave I 123 
amplitude for Veterans with high levels of reported noise exposure during their military service 124 
and non-Veterans who reported firearm use compared to non-Veterans with less noise exposure 125 
(Figure 2). Liberman et al. (2016) showed a reduction in the amplitude ratio of the ABR summating 126 
potential (SP) to the action potential (AP; equivalent to wave I of the ABR) in college music 127 
students (age 18-41) with high levels of reported noise exposure versus non-music students with 128 
lower reported noise exposure histories (Figure 3). It must be noted that using the Wave 1/SP ratio 129 
can be problematic as a normalizing strategy since the ratio is critically dependent on changes in 130 
the denominator. Stamper and Johnson (2015a) reported a reduction in ABR wave I amplitude for 131 
young people (age 19-28) with higher reported recreational noise exposure compared to individuals 132 
with lower exposure, but a reanalysis showed that this relationship held true only for female 133 
participants (Stamper & Johnson 2015b). In a group of older adults (aged 29-55) with pure tone 134 
thresholds ranging from normal to mild hearing loss, Valderrama et al. (2018) reported a significant 135 
relationship between lower ABR wave I amplitude and increasing lifetime noise exposure.  136 
 137 
Human envelope following response studies of noise-induced synaptopathy 138 
The envelope following response (EFR) is an evoked potential generated in response to 139 
amplitude modulated sounds (often a sinusoidally amplitude modulated pure tone) that can be 140 
measured from electrodes placed on the scalp. The EFR provides an indication of the fidelity 141 
with which the auditory system can follow the envelope of a stimulus (Dolphin & Mountain 142 
1992). Two studies demonstrated that EFR strength was reduced in mice with histologically 143 
confirmed synapatopathy that was either induced through ageing (Parthasarathy & Kujawa 2018) 144 
or noise exposure (Shaheen et al. 2015). The EFR was most sensitive to synaptopathy for 145 
stimulus modulation frequencies between 700 and 1000 Hz, which is consistent with the EFR 146 
being generated at the AN. However, it is unclear how these animal results will translate to 147 
humans, where the EFR is generally measured at much lower modulation frequencies (80-120 148 
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Hz), targeting EFR generators from the auditory midbrain. Bharadwaj et al. (2015) detected a 149 
marginally significant difference in the EFR slope and envelope interaural time difference (ITD) 150 
threshold when participants were grouped as “more” and “less” noise exposed, but argued this 151 
result should be interpreted with caution based on the crude characterization of noise-exposure 152 
history, small sample size, and cross-correlations among the temporal coding outcomes. While 153 
simulation studies based on functional models of the auditory periphery show a role for 154 
synaptopathy in reduced EFR strength (Bharadwaj et al. 2014; Paul et al. 2017; Verhulst et al. 155 
2018a; Verhulst et al. 2018b), it remains unclear whether the EFR is a robust marker for noise-156 
induced synaptopathy in humans. One potential confound is that animal experiments have shown 157 
that EFR remains normal as long as there is the capacity to maintain neural gain suggesting that 158 
top-down activity, including cognition and memory capabilities, can influence neural responses 159 
in the brainstem (Möhrle et al. 2016). These findings suggest that future studies should consider 160 
how top-down mechanisms influence the periphery, especially for aged populations.  161 
Furthermore, with better detection tools, other factors that may contribute to impaired neural 162 
processing may become feasible to assess, such as potentially detrimental effects of 163 
corticosterones and/or potentially beneficial effects of systemic corticosteroids on auditory 164 
processing (Singer et al., 2018). 165 
   166 
Data consistent with an impact of synaptopathy on auditory perception 167 
One advantage of looking at perceptual consequences of synaptic/neural dysfunction is that 168 
uncertainties about the reliability of noise exposure questionnaires and their comparability across 169 
studies can be taken out of the equation. Instead, a physiological measure (e.g. ABR wave I 170 
amplitude, ABR wave I/V amplitude ratio, EFR strength, middle-ear-muscle reflex (MEMR) 171 
strength) can be directly compared to, or correlated with, the perceptual measure.  172 
 173 
Tinnitus. Consistent with animal models of cochlear synaptopathy, where ABR wave I amplitude 174 
is reduced (Kujawa & Liberman 2009; Furman et al. 2013; Sergeyenko et al. 2013), several studies 175 
have shown a relationship between reduced wave I amplitude (or reduced wave I/V ratio) and 176 
tinnitus (Schaette & McAlpine 2011; Gu et al. 2012; Bramhall et al. 2018; Valderrama et al. 2018). 177 
It is not completely clear why the amplitude of wave V remains close to normal despite the inferred 178 
synaptopathy in tinnitus patients, although enhanced central gain after IHC loss can be a possible 179 
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explanation for this phenomenon (for review see Salvi et al. 2016). Decreased responses for two 180 
other physiological measures that are sensitive to synaptopathy in mouse models, the MEMR and 181 
the EFR (Shaheen et al. 2015; Valero et al. 2016; Valero et al. 2018), have been associated with 182 
tinnitus in humans as well. In individuals with tinnitus who have normal or near-normal 183 
audiograms, Wojtczak et al. (2017) observed a weakened MEMR relative to age- and sex-matched 184 
controls. Paul et al. (2017) showed EFR reductions for individuals with normal audiograms and 185 
tinnitus compared to those without tinnitus. However, reanalysis after identification of a statistical 186 
error revealed that this was not a significant effect (Roberts et al. 2018). 187 
 188 
Hyperacusis. The lack of a uniform measure of hyperacusis makes this perceptual deficit difficult 189 
to assess. Bramhall et al. (2018) did not observe a relationship between loudness discomfort level 190 
(LDL) and ABR wave I amplitude, but this may be because LDL alone is not a good indicator of 191 
hyperacusis (Sheldrake et al. 2015; Zaugg et al. 2016). Liberman et al. (2016) showed that their 192 
high noise exposure group was more likely to report annoyance of everyday sounds and avoidance 193 
of noisy environments than their low noise exposure group. However, neither their noise exposure 194 
nor their hyperacusis questionnaire was validated. In addition, although they showed a reduction 195 
in SP/AP ratio in their high noise exposure group, they did not specifically analyze the relationship 196 
between responses on the hyperacusis questionnaire and ABR measures. Given that the high noise 197 
exposure group had significantly poorer extended high frequency (EHF) thresholds than the low 198 
noise exposure group, this may account for the increased reporting of sound tolerance problems in 199 
the high noise exposure group.  200 
 201 
Speech-in-noise performance. Theoretical reasoning predicts that synaptopathy should degrade 202 
the neural coding of speech, particularly in noise, and thus hinder the intelligibility of speech in 203 
noise (Lopez-Poveda & Barrios 2013; Lopez-Poveda 2014). Liberman et al. (2016) found a 204 
relationship between SP/AP ratio and speech-in-noise performance in young males, the significant 205 
differences in the EHF thresholds of the two groups could have impacted speech-in-noise 206 
performance (Badri et al. 2011; Yeend et al. 2017).  Prendergast et al. (2018) reported the SP/AP 207 
ratio had considerably less test-retest reliability than wave I amplitude within their normal hearing 208 
cohort.  In a sample that included participants up to age 55 with pure tone thresholds ranging from 209 
normal to mild high frequency hearing loss, Valderrama et al. (2018) observed an interaction effect 210 
8 
 
of the ABR wave I/V amplitude ratio and wave V-I interpeak latency on speech-in-noise 211 
performance, suggesting that slower neural conduction is associated with poorer performance. 212 
While average high-frequency and EHF auditory thresholds did not appear to be predictive of 213 
speech perception performance in this sample, this does not rule out the possibility that subclinical 214 
OHC dysfunction may have contributed to the relationship between the ABR metrics and speech 215 
perception performance. Although the impact of synaptopathy on speech perception in people with 216 
normal audiograms may be limited, it is important to remember that synaptopathy likely co-exists 217 
with audiometric loss in many cases of SNHL, and that in the context of OHC dysfunction, 218 
synaptic/neuronal loss may have a greater impact on speech perception. This is supported by the 219 
findings of Bramhall et al. (2015) showing an interaction effect of average pure tone thresholds (at 220 
0.5, 1, 2, and 4 kHz) and ABR wave I amplitude on performance on the QuickSIN intelligibility 221 
test, with a stronger relationship between ABR wave I amplitude and QuickSIN performance 222 
(poorer performance for lower wave I amplitudes) in individuals with elevated pure tone 223 
thresholds. In addition to these peripheral effects, central factors such as attention, working 224 
memory and language, are also important factors that affect speech-in-noise performance (Yeend 225 
et al. 2017) and likely interact with any peripheral encoding deficits, thus contributing to the wide 226 
variation observed in speech-in-noise performance across individuals with similar audiograms 227 
(Johannesen et al. 2016; Lopez-Poveda et al. 2017). 228 
 229 
Performance on suprathreshold psychoacoustic tasks. Synaptopathy likely degrades the neural 230 
coding of acoustic information, particularly in noise (e.g., Lopez-Poveda 2014). The relationship 231 
between auditory encoding of complex stimuli and performance on basic psychoacoustic tasks such 232 
as amplitude modulation detection, temporal fine-structure sensitivity, tone-in-noise detection, 233 
frequency and intensity discrimination, and binaural interaural time difference (ITD) or interaural 234 
level difference (ILD) sensitivity are not well understood. Numerous studies have investigated the 235 
relationship between these metrics over the years with mixed outcomes, even for listeners with 236 
clinically normal hearing (Strelcyk & Dau 2009; Hopkins & Moore 2011; Fullgrabe et al. 2014; 237 
Stone & Moore 2014; Prendergast et al. 2017a; Yeend et al. 2017; Valderrama et al. 2018). Without 238 
a better understanding of the relationship between physiological metrics (often representing a 239 
population response to a click or AM stimulus) and performance on a psychoacoustic task, we run 240 
the risk of comparing apples to oranges, as a single synaptopathy profile may have differing effects 241 
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on physiological measures versus psychoacoustic tasks. Numerical modelling approaches can 242 
improve our ability to compare potential metrics of synaptopathy by predicting the expected impact 243 
of synaptopathy and/or OHC/IHC deficits on each measure (Verhulst et al. 2016; Encina-Llamas 244 
et al. 2017; Paul et al. 2017; Carney 2018; Verhulst et al. 2018b).  245 
 246 
Biophysical models of the human auditory periphery have suggested an impact of synaptopathy on 247 
the encoding of suprathreshold sounds. Bharadwaj et al. (2014) modelled the effect of a complete 248 
loss of low-SR AN fibers on the population response of the inferior colliculus (IC) (a proxy for the 249 
dominant source generators of the EFR) (Melcher & Kiang 1996) for an 80 dB SPL 100% 250 
sinusoidally AM pure tone embedded in notched noise and found a 7 dB reduction in the magnitude 251 
of the response. This study did not consider the impact of this reduction on a specific 252 
psychoacoustic task, but degraded coding of AM information at the level of the IC is expected to 253 
impair performance on a psychoacoustic AM detection task. Verhulst et al. (2018b) expanded on 254 
these findings by using a numerical model of the human auditory periphery  to compute the impact 255 
of synaptopathy and OHC loss on the EFR, AM and tone-in-noise detection threshold. Complete 256 
low-SR fiber loss was predicted to elevate the 4-kHz AM detection threshold by 2 dB, and an 257 
additional loss of 50% or 75% of the high-SR fiber population resulted in an AM detection 258 
threshold shift of 8 dB and 15 dB, respectively. The simulations also showed that individual 259 
differences in AM detection were well correlated to the EFR (in response to a 100% amplitude-260 
modulated tone) and that synaptopathy, rather than OHC deficits, was the main factor driving 261 
individual differences in AM detection performance for listeners with normal audiograms and those 262 
with sloping high frequency hearing loss. The simulations furthermore predicted the need for a 4-263 
dB stimulus signal increase for a synaptopathy model (100% low-SR loss and 50% high-SR fiber 264 
loss) to reach the same performance on a 4-kHz tone-in-noise detection task as a normal-hearing 265 
model. The simulated tone-in-noise detection differences on the basis of different degrees of 266 
synaptopathy were consistent with behavioural chinchilla tone-in-noise detection threshold shifts 267 
in the range of 5-10 dB when more than 60% of the IHC population was lost (Lobarinas et al. 268 
2016). Paul et al. (2017) showed that a simulated loss of low and medium SR fibers (based on the 269 
Zilany et al. (2014) model) was sufficient to account for individual differences in AM detection 270 
thresholds for a 5 kHz pure tone among individuals with normal hearing. In another simulation 271 
model, Carney (2018) suggested that synaptopathy may alter spectral contrasts across the cochlear 272 
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partition, which could impair encoding of speech. These studies suggest that model simulations are 273 
a promising method for disentangling the role of different AN fiber populations on suprathreshold 274 
auditory perception as well as the interaction between synaptopathy and OHC/IHC dysfunction.  275 
 276 
 277 
Data Inconsistent with Noise-Induced Synaptopathy in Humans 278 
As outlined earlier, there are two basic approaches to the search for noise-induced cochlear 279 
synaptopathy in humans. The first is to determine if noise exposure is associated with neural 280 
deficits (wave I amplitude changes) consistent with those observed in animals with histologically 281 
confirmed synaptopathy. The second is to determine whether or not noise exposure (with or without 282 
changes in evoked potential measurements) is associated with a measurable change in auditory 283 
function (difficulties understanding speech in complex listening situations).  284 
 285 
A number of studies have used the first approach, specifically, seeking evidence of neural deficits 286 
that parallel those observed in rodent models. To reduce the probability of inclusion of participants 287 
with significant OHC loss, human studies have largely recruited listeners with hearing thresholds 288 
within the clinically normal range (≤ 20 dB HL) and measured the amplitude of wave I of the ABR, 289 
the measure of AN function that is associated with synaptopathy in the rodent models (Kujawa & 290 
Liberman 2009; Sergeyenko et al. 2013). It needs to be mentioned that there are several 291 
morphological differences between rodent and human auditory neurons that could explain the 292 
difficulty in detecting synaptopathy in humans. For example, the total number of spiral ganglion 293 
cells and AN fibers differ and in contrast to rodents, nerve fibers in humans are rarely myelinated 294 
(Kimura et al. 1979; Nadol Jr 1988).  295 
 296 
The majority of studies have failed to find a significant relation between questionnaire- or 297 
interview-based estimates of noise exposure and wave I amplitude, for participants with normal 298 
audiometric hearing (Fulbright et al. 2017; Grinn et al. 2017; Guest et al. 2017b; Prendergast et al. 299 
2017a; Spankovich et al. 2017; Prendergast et al. 2018; Johannesen et al. 2019) (Figures 4 and 5). 300 
The largest study to date (126 participants) used a comprehensive lifetime noise interview to 301 
estimate noise exposure history but failed to detect significant decreases in wave I amplitude with 302 
increasing noise exposure, despite the presence of EHF hearing loss (Prendergast et al. 2017a), 303 
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raising questions about the prevalence of this pathology in humans with “typical” noise histories. 304 
Also of interest is the study of Fulbright et al. (2017), who collected data using the same 305 
methodology and stimulus conditions as the earlier study by Stamper and Johnson (2015a). A 306 
reanalysis of this earlier study by sex reported a significant correlation between noise exposure and 307 
wave I for female participants, but not males (Stamper & Johnson 2015b). However, when 308 
Fulbright et al. added their data to those of Stamper and Johnson, the effect was no longer 309 
significant for females either, suggesting that this original result may have been a statistical fluke. 310 
Several other groups have used the noise exposure questionnaire (NEQ) as used by Stamper and 311 
Johnson, without finding statistically significant relationships between NEQ scores and wave I 312 
amplitude (Grinn et al. 2017; Spankovich et al. 2017; Ridley et al. 2018). Skoe and Tufts (2018) 313 
did not detect differences in wave I amplitude, although they did report delayed latencies of waves 314 
I through V, with increasing delays for later waves. In this study, the participants were divided into 315 
low- and high-exposure groups based on noise dosimetry over a one-week period. 316 
 317 
As indicated earlier, another potential electrophysiological measure of synaptopathy that has 318 
received attention is the EFR, which has been suggested as a sensitive measure of low-SR fiber 319 
loss, especially at high stimulus levels and shallow modulation depths (Bharadwaj et al. 2014; 320 
Bharadwaj et al. 2015). Again, however, the evidence for an association with noise exposure is 321 
weak. Prendergast et al. (2017a), Guest et al. (2017b), and Grose et al. (2017) have all reported no 322 
significant relation between lifetime noise exposure and EFR amplitude. 323 
 324 
Studies failing to find evidence that noise-induced cochlear synaptopathy is functionally 325 
significant in humans 326 
The second basic approach taken in studies of noise-induced cochlear synaptopathy in humans is 327 
to determine whether or not noise exposure (with or without changes in evoked potential 328 
measurements) is associated with a measurable change in auditory function. Recent studies that 329 
have taken this approach have provided little evidence that noise exposure is related to perceptual 330 
deficits for listeners with normal audiometric hearing. In a study of 138 participants aged 18-36 331 
with clinically normal hearing, Prendergast et al. (2017b) reported little relation between lifetime 332 
noise exposure and a range of perceptual measures, including frequency discrimination, intensity 333 
discrimination, interaural phase discrimination, amplitude modulation detection, auditory 334 
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localization, musical consonance perception, and speech perception in noise (SPiN). Similarly, in 335 
an older cohort of 122 participants aged 30-57, Yeend et al. (2017) reported no relation between 336 
lifetime noise exposure and a range of auditory processing and SPiN tasks. Le Prell et al. (2018) 337 
similarly failed to detect any statistically significant relations between common sources of noise 338 
exposure and performance on a word-in-noise test. These null results are consistent with several 339 
other studies (Fulbright et al. 2017; Grinn et al. 2017; Grose et al. 2017; Guest et al. 2018). 340 
 341 
Another approach that avoids issues with the unreliability of self-reported noise exposure is to 342 
determine whether or not perceptual deficits are associated with physiological measures assumed 343 
to reflect cochlear synaptopathy. Several recent studies have reported no relation between ABR 344 
wave I amplitude and SPiN (Fulbright et al. 2017; Grinn et al. 2017; Prendergast et al. 2017b; 345 
Bramhall et al. 2018; Guest et al. 2018), nor between EFR amplitude and SPiN (Prendergast et al. 346 
2017b; Guest et al. 2018) (Figure 6). With regard to tinnitus, Gilles et al. (2016), Guest et al. 347 
(2017a; 2017b), and Shim et al. (2017), have each reported no relation between presence of tinnitus 348 
and wave I amplitude for participants with normal audiometric hearing. Guest et al. (2017a; 2017b) 349 
also reported no significant reduction in EFR amplitude in their tinnitus participants compared to 350 
controls. 351 
 352 
Possible explanations for null results and differences between studies. 353 
It is invalid to assume that a non-significant result implies that the null hypothesis has been proven. 354 
The following comments offer potential reasons for null results and differences in outcomes across 355 
studies. Many of the issues noted below have the net effect of reducing statistical power, as they 356 
introduce variability into the data. 357 
 358 
Humans may be less vulnerable to noise-induced synaptopathy than rodents.  359 
Cochlear synaptopathy is observed with ~100 dB SPL two-hour octave band exposures in the 360 
mouse (Kujawa & Liberman 2009), ~106 dB SPL two-hour octave band exposures in the guinea 361 
pig (Lin et al. 2011), and ~109 dB SPL two-hour octave band exposures in the rat (Lobarinas et al. 362 
2017).  Decreasing sound levels by 3 dB can eliminate synaptopathic injury (see Fernandez et al. 363 
2015), whereas increasing sound levels by 3 dB can intensify the injury to include permanent 364 
threshold shift (Lin et al. 2011).  Macaque monkeys are more resistant to cochlear synaptopathy 365 
13 
 
than rodents (Valero et al. 2017), resulting in predictions that humans are less susceptible to noise-366 
induced synaptopathy than rodents (Dobie & Humes 2017). Given the high intensity levels needed 367 
to produce acoustic trauma resulting in significant temporary threshold shift and bordering on a 368 
permanent threshold shift, there may be few human exposures that will result in the large reductions 369 
in ABR wave I seen in the original mouse study (Kujawa & Liberman 2009).  If so, this would 370 
make selective noise-induced cochlear synaptopathy harder to detect in humans. Indeed, when 371 
Dobie and Humes adjusted for inter-species differences in susceptibility to noise-induced 372 
temporary threshold shift, they found that the noise exposures that cause neuropathy in rodents, 373 
when translated to the equivalent levels predicted to be needed to induce cochlear synaptopathy in 374 
humans, exceed the OSHA permissible exposure limits. This suggests that the noise exposure 375 
levels that are synaptopathic for humans may already be addressed by current noise exposure 376 
guidelines.  377 
 378 
The range of exposures inducing selective cochlear synaptopathy may be narrow. 379 
In a recent macaque study, noise exposures producing a temporary threshold shift were 380 
associated with only a 12-27% loss of synapses (Valero et al. 2017) versus 40-55% loss in rodent 381 
models (Kujawa & Liberman 2009; Lin et al. 2011; Hickox et al. 2017). Given that primates 382 
appear more resistant to noise-induced synaptopathy than mice (Kujawa & Liberman 2009; 383 
Valero et al. 2017), there may only be a narrow “sweet spot” where noise-induced cochlear 384 
synaptopathy can occur while hearing thresholds are still clinically normal. This sweet spot 385 
would be characterized by sufficient synaptopathy to be detectable via ABR amplitude 386 
measurements (or another less variable, more reliable metric), but with overall cochlear damage 387 
low enough that OHCs are intact and hearing thresholds are normal. It is possible that this “sweet 388 
spot” is often the result of a combination of noise- and age-related synaptopathy. Support for this 389 
suggestion comes from the observation that several studies investigating young people with 390 
recreational noise exposure or tinnitus have failed to find evidence for synaptopathy in ABR 391 
wave I amplitude measurements (Fulbright et al. 2017; Grinn et al. 2017; Guest et al. 2017b; 392 
Prendergast et al. 2017a; Guest et al. 2018), whereas studies in slightly older cohorts (Schaette & 393 
McAlpine 2011; Gu et al. 2012; Valderrama et al. 2018) did find reductions in ABR wave I 394 
amplitude in the experimental group. There is also the possibility that partial synaptic repair may 395 
occur in humans following noise exposure. This phenomenon has been observed in noise-396 
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exposed guinea pigs (Liu et al. 2012; Shi et al. 2016) and if also prevalent in humans, it would be 397 
yet another source of variation impacting our ability to find evidence for synaptopathy.   398 
 399 
Sound evoked potentials are more variable in humans than in rodents. In the study of 400 
Prendergast et al. (2018), the coefficient of variation in wave I amplitude was 25% in the low noise 401 
exposure group, which may indicate a large degree of variability compared to the effect being 402 
measured. One of the factors that may contribute to the between-subject variability and reduced 403 
statistical power for detection of differences in human electrophysiological measures is head size 404 
and geometry (Mitchell et al. 1989; Don et al. 1994); this may contribute to differences in the average 405 
ABR wave I amplitude for males and females, with smaller average wave I amplitudes in males than 406 
in females. Cochlear duct length also varies with sex, with longer duct length in males than in females 407 
(Sato et al. 1991; Thong et al. 2017). The higher noise floor of human ABR wave I amplitude 408 
measurements is another potential source of variability. Humans are tested while unanesthetized 409 
(with a variable sleep state) and with dermal or ear canal electrodes, while rodents are tested while 410 
anesthetized using subcutaneous needle electrodes. An additional aspect that needs further 411 
investigation is the possibility that top-down regulation might be playing a role. 412 
 413 
The sensitivity of the auditory brainstem response to human synaptopathy might be 414 
inadequate.  415 
Most human studies have employed ABR amplitude measurements to assess cochlear synaptopathy 416 
(Schaette & McAlpine 2011; Gu et al. 2012; Stamper & Johnson 2015a; Liberman et al. 2016; 417 
Bramhall et al. 2017; Fulbright et al. 2017; Grinn et al. 2017; Grose et al. 2017; Guest et al. 2017b; 418 
Prendergast et al. 2017a; Shim et al. 2017; Bramhall et al. 2018; Guest et al. 2018; Valderrama et 419 
al. 2018). In these studies, a decrease in the amplitude of ABR wave I relative to wave V has been 420 
interpreted as evidence for cochlear synaptopathy and  based on speculation that wave V amplitude 421 
is “normal” as a consequence of the compensatory central gain observed in animal models (see 422 
Salvi et al. 2017).  The interpretation of wave I/V ratios must be considered hypothetical at this 423 
time, as central gain as a compensatory mechanism subsequent to the loss of synapses in the cochlea 424 
is highly speculative and not well understood. It is possible that not all cases of synaptopathy lead 425 
to increased central gain. Using ABR wave I amplitude as an indicator of synaptopathy is further 426 
complicated by the fact that high frequency OHC loss also reduces the wave I ABR amplitude by 427 
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decreasing the contribution of high frequency AN fibers to the ABR generation (e.g., Lewis et al. 428 
2015; Verhulst et al. 2016). In addition, it must be remembered that the OHCs provide significant 429 
level-dependent amplification of the cochlear response, and loss of the OHCs decreases the input 430 
to the IHCs (Dallos et al. 2006; for recent review see Le Prell 2019). This makes it difficult to use 431 
ABR wave I amplitude to diagnose  synaptopathy when OHC dysfunction is also present. Thus, 432 
synaptopathy might remain “hidden” even if ABR amplitude measurements are added to the 433 
audiometric test battery.  434 
In addition, the results of Bourien et al. (2014) suggest that ABR wave I amplitudes might not be 435 
a particularly sensitive measure of low-SR synaptopathy. In a series of measurements in gerbils, 436 
Bourien et al. showed that low-SR AN fibers have a minimal contribution to the amplitude of ABR 437 
wave I. This suggests that the sensitivity of wave I amplitude to low-SR synaptopathy is limited. 438 
There are, however, indications, that low-SR fibers might be more important in controlling the 439 
efferent system than in encoding of high-intensity sound levels (Carney 2018). This is also 440 
consistent with the modeling work in Encina-Llamas et al. (2017) where the EFR is dominated by 441 
off-frequency high-SR fibers. Removing all low-SR fibers shows hardly any contribution in a 442 
model based on AN responses. Interestingly, when Furman et al. (2013) demonstrated particular 443 
vulnerability of low-SR fibers to synaptopathy, they binned the low- and medium-SR fibers 444 
together in their analysis. Therefore, the possibility for a significant contribution of medium and 445 
high-SR fiber loss to synaptopathy (and ABR wave I amplitude) should also be considered.  446 
 447 
The sensitivity of the envelope following response to human synaptopathy might be 448 
inadequate. In addition to the concerns noted above, there are other factors that suggest the second 449 
main electrophysiological measure of synaptopathy in rodents, EFR amplitude, may also be 450 
insensitive to synaptopathy in humans, consistent with the lack of a clear reduction in EFR strength 451 
in individuals with a history of noise exposure. Modelling of AN activity suggests that low-SR 452 
fibers have limited contribution to the EFR at high stimulus levels and that amplitude fluctuations 453 
in the stimulus are coded by the activity of high-SR fibers at frequencies basal to the frequency of 454 
the stimulus (Encina-Llamas et al. 2017). Accordingly, low-SR fiber loss will not impact the EFR 455 
due to the large population of high-SR fibers contributing to the response. Empirical data will be 456 
necessary to resolve these questions, given discrepancies in predictions across the various modeling 457 
efforts. Furthermore, as noted earlier, in the mouse model, the EFR is sensitive to synaptopathy at 458 
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high modulation rates (around 1 kHz and above) but does not seem to be sensitive to synaptopathy 459 
at the lower rates (typically 100 Hz) used in the human studies (Shaheen et al. 2015).  460 
 461 
Variability in the noise-exposed populations studied could underlie observed differences in 462 
results and conclusions. Most studies of noise-induced synaptopathy have investigated young 463 
people with clinically normal hearing and high versus low recreational noise exposure (e.g. 464 
concerts, personal music player use, etc.). Many of these studies have not found an effect of noise 465 
exposure on suprathreshold ABR wave I amplitude, either using the noise exposure survey scores 466 
as a continuous variable or when participants are sorted into high and low exposure groups using 467 
survey data (Fulbright et al. 2017; Grinn et al. 2017; Prendergast et al. 2017a). Similarly, 468 
Holtegaard & Epp (2018) found no difference in ABR wave I amplitude for individuals with a 469 
history of occupational noise exposure (musicians and flight attendants) compared to controls with 470 
less reported noise exposure. In contrast, studies of young music students (Liberman et al. (2016) 471 
and  young female adults (Stamper & Johnson 2015a, 2015b) have found electrophysiological 472 
differences as a function of noise exposure history, consistent with synaptopathy. The few studies 473 
that have included older participants or individuals with higher levels of noise exposure have found 474 
noise exposure-related reductions in ABR wave I amplitude (Bramhall et al. 2017; Valderrama et 475 
al. 2018). Common recreational exposures and many occupational exposures are very different 476 
from the high-intensity military noise and firearms to which Bramhall et al.’s participants were 477 
exposed. If it is the case that humans are not as susceptible as rodents to noise-induced 478 
synaptopathy (Dobie & Humes 2017; Valero et al. 2017), then it is likely that the intensity levels 479 
of many common sources of recreational noise exposure are simply not high enough to cause 480 
synaptopathy.   481 
 482 
Differences in OHC function between control and experimental groups could confound 483 
results and interpretation. Even among young people with normal audiograms, subclinical OHC 484 
dysfunction is more likely in those with noise exposure than those without. This could affect 485 
electrophysiological and perceptual measures, leading to between-group differences that are not 486 




Variability in the tinnitus populations used across studies could underlie observed differences 489 
in results and conclusions. Recruitment strategies across studies investigating ABR wave I 490 
amplitude and tinnitus have varied (Schaette & McAlpine 2011; Gu et al. 2012; Guest et al. 2017b; 491 
Shim et al. 2017; Bramhall et al. 2018), which may contribute to the differing results. Tinnitus is a 492 
heterogeneous disorder with noise exposure as one possible cause. Other etiologies of tinnitus 493 
include head/neck trauma, medications, thyroid problems, cardiovascular disease, acoustic 494 
neuroma, Meniere’s disease, etc. (Henry et al. 2014). When subjects are recruited specifically based 495 
on their report of tinnitus, it is expected that there will be a mix of underlying etiologies for the 496 
tinnitus. However, if a study recruits for noise exposure and then looks at the subgroup of noise-497 
exposed participants that have tinnitus, that tinnitus group is more likely to have predominantly 498 
noise-induced tinnitus. 499 
 500 
Functional metrics are variable; some tests may not have adequate sensitivity or specificity. 501 
It is also perhaps unsurprising that it has proven difficult to find evidence that synaptopathy leads 502 
to deficits in behavioral performance. Oxenham (2016) has argued, from a signal detection theory 503 
perspective, that the effects of even 50% deafferentation may be insignificant perceptually. Other 504 
perceptual (Lopez-Poveda & Barrios 2013; Marmel et al. 2015) and computational models, 505 
however, suggest larger effects (4-7 dB) (Paul et al. 2017; Verhulst et al. 2018b) depending on the 506 
stimulus characteristics and the amount of deafferentation. Empirical data are needed to assess 507 
these varied model predictions. However, the models recently described by Carney (2018) suggest 508 
an even more fundamental paradigm change may be necessary, arguing against a direct role of low- 509 
and medium-SR fibers in coding sounds at moderate to high sound levels.  510 
 511 
Many auditory and non-auditory factors, such as memory and attention, are known to contribute to 512 
behavioral tasks such as SPiN (Yeend et al. 2017), and the contribution of synaptopathy may be 513 
relatively small, at least for listeners with clinically normal audiograms. Additional research is 514 
needed to determine the relative contributions of OHC function, cochlear synaptopathy, memory, 515 
attention, and other factors on auditory perception. If associations between cochlear synaptopathy 516 
and perceptual issues cannot ultimately be reliably measured, even in individuals with significant 517 
synaptic loss, such results would raise questions as to whether noise-induced cochlear synaptopathy 518 
should be regarded as a major hearing health issue. While cross-sectional retrospective study 519 
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designs are useful and powerful, longitudinal studies allowing the trajectory of change to be 520 
established in parallel across a detailed test battery would be helpful in more completely answering 521 
these questions. 522 
 523 
Noise exposure history metrics are variable and imprecise exposure measurements introduce 524 
variability. Different groups have used a variety of measures of self-reported noise exposure 525 
history in their studies of noise-induced synaptopathy (Bharadwaj et al. 2015; Stamper & Johnson 526 
2015a; Liberman et al. 2016; Bramhall et al. 2017; Grinn et al. 2017; Grose et al. 2017; Paul et al. 527 
2017; Prendergast et al. 2017a; Yeend et al. 2017; Holtegaard & Epp 2018). Although synaptopathy 528 
can theoretically be induced by noise exposure experienced at any point in an individual’s lifetime, 529 
some of these metrics assess noise exposure only during the previous year or two rather than over 530 
their lifetime. Although participants were excluded if they reported that the previous year was not 531 
representative of historic exposure, surveys based on the previous year have not been validated 532 
against lifetime surveys. Except for Bramhall et al. and Yeend et al., these noise exposure measures 533 
either do not specifically ask about firearm use or they do not incorporate firearm exposure into 534 
the overall noise exposure score because they use a scoring system that does not allow for both 535 
continuous and impulse/impact noise exposures. However, this is probably not a significant 536 
confound for the European studies, where firearm use is minimal. In addition, all self-report 537 
measures are dependent on the recall ability of the participants. This makes noise exposure history 538 
questionnaires a relatively crude metric that is prone to measurement error. There is no consensus 539 
on which noise exposure questionnaire should be used for studying synaptopathy or how to score 540 
it, making comparisons across studies difficult.  541 
 542 
It has been argued that the imprecision of the self-report noise exposure metrics is small compared 543 
to the range of noise exposures in the sample of participants used in some studies. For example, in 544 
one study reporting a null result for ABR wave I, the low- and high-exposure groups differed by 545 
an average of a factor of 340 in terms of estimated lifetime energy of exposure (Prendergast et al. 546 
2018). The mean exposure for the low-noise group in this study was equivalent, in terms of total 547 
energy, to that for an individual who goes to a nightclub or live music event for 1.5 hours, once per 548 
year, for 5 years. The mean high-noise exposure was equivalent to going to the same event for 3 549 
hours, three times per week, every week of the year, for 5 years. It seems unlikely that participants’ 550 
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recollection of exposures would be so poor as to be unable to distinguish between these. 551 
Furthermore, the lifetime noise-exposure measure used by Prendergast, Guest, and colleagues, was 552 
significantly correlated with 16-kHz thresholds (Prendergast et al. 2017a) and with the presence of 553 
tinnitus (Guest et al. 2017b), suggesting that this measure is reliable.  However, measurement error 554 
in estimates of noise exposure remains a significant concern. The potential for errors associated 555 
with the assignment of sound intensity levels to recreational exposures is highlighted by Le Prell 556 
et al. (2018), who measured preferred music player listening levels across multiple songs per 557 
subject. Even within a quiet lab setting, individual subjects had significant variability in their level 558 
selections on a song-to-song basis. These data raise questions about the validity of assigning a 559 
relatively arbitrary intensity level for calculating accumulated noise exposure over the past year or 560 
longer periods of time. Differences in accumulated noise dose are highly variable across events 561 
and individuals, as a function of differences in event intensity level, distance from the sound source, 562 
and duration of event attendance (see for example, the event specific exposure data in Grinn et al., 563 
(2017)). 564 
 565 
Control groups may differ across studies. In group comparisons, it is vital that the control 566 
population has limited noise exposure, otherwise the presence of people with synaptopathy in the 567 
control group will make it difficult to detect differences between the control and experimental 568 
groups. Ensuring a control group with limited noise exposure is difficult due to the inherent 569 
limitations of using noise exposure questionnaires. An in-depth noise exposure questionnaire with 570 
specific questions about a variety of potentially noisy activities rather than a questionnaire that uses 571 
more general questions to assess noise exposure history may be necessary to aid recall of noise 572 
exposures in potential study participants, particularly for infrequent exposures. Given the results 573 
from Bramhall et al. (2017) suggesting that firearm users have reduced ABR wave I amplitudes, 574 
even individuals with a single episode of firearm exposure should not be included in a control 575 
group. Confirming good OHC function by screening for otoacoustic emissions (OAEs) and/or EHF 576 
thresholds will also help ensure this population does not have noise exposure history that they have 577 
forgotten to report. It is also possible that most adult humans have some degree of age-related 578 
and/or noise-induced synaptopathy, making it difficult to identify a true control population, and 579 




Positive results may be due to audiometric confounds unrelated to synaptopathy. Several 582 
studies have provided intriguing evidence that could support an interpretation of an underlying 583 
synaptopathic injury. However, there are potential confounds in some of these studies that should 584 
be considered. Some studies that have reported a relation between ABR measures of synaptopathy 585 
and noise exposure have either reported high-frequency audiometric differences between low-noise 586 
and high-noise groups (Liberman et al. 2016; Bramhall et al. 2017), or have not measured 587 
audiometric thresholds at extended high frequencies above 8 kHz (Stamper & Johnson 2015a, 588 
2015b). Bramhall et al. (2017) reported a 2-6 kHz threshold elevation compared to controls for one 589 
of their high-noise groups (“veteran high noise”), but not the other (“non-veteran firearms”). 590 
However, they controlled for variability in OHC function in their analysis by statistically adjusting 591 
for DPOAE differences between the groups. It is unclear the extent to which small audiometric 592 
differences might influence the electrophysiological measures of synaptopathy, although it is 593 
known that ABR wave I amplitude is dependent on basal cochlear generators (Don & Eggermont 594 
1978). Valderrama et al. (2018) reported a weak but significant relation between lifetime noise 595 
exposure and ABR wave I amplitude, even after controlling for audiometric thresholds. Although 596 
this was a relatively large sample with careful documentation of lifetime exposure to noise, the 597 
authors note that if a single outlier with extremely low noise and an extremely robust ABR wave I 598 
amplitude was excluded from the analysis, the observed association between lifetime noise 599 
exposure and ABR wave I amplitude was no longer statistically significant.  600 
 601 
Some of the positive findings with respect to tinnitus and synaptopathy may also have been affected 602 
by audiometric differences. In the Gu et al. (2012) study the groups were not audiometrically 603 
matched for the click level (120 dB peSPL) at which a significant effect on wave I amplitude was 604 
observed, with higher thresholds in the tinnitus group at frequencies of 8 kHz and above. In the 605 
Bramhall et al. (2018) study there were also audiometric differences between the groups, although 606 
the authors controlled for DPOAE differences in the analyses. In the Schaette and McAlpine (2011) 607 
study there was a small audiometric threshold elevation (3.5 dB) in the tinnitus group at 12 kHz, 608 
and thresholds at higher frequencies were not reported. Wojtczak et al. (2017), who reported a large 609 
reduction in the acoustic MEMR amplitude in their tinnitus participants compared to controls, also 610 
observed substantial audiometric differences between groups. Although the effect of group was 611 
still highly significant after controlling for audiometric threshold, the pure tone threshold 612 
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measurements were limited to a minimum of 0 dB HL, which may have biased thresholds for the 613 
controls upwards. It is unclear, however, if this could account for the large group differences in 614 
MEMR amplitude they observed. 615 
 616 
Reproducibility is a major concern. Finally, we should be aware of the crisis in the wider 617 
neuroscience community regarding reproducibility (Colquhoun 2017). Many of the human 618 
studies of synaptopathy have used a large number of outcome measures. Studies have often 619 
reported positive effects for one measure but not others, and the statistical significance of the 620 
positive effects has often been marginal (and usually uncorrected for multiple comparisons). In 621 
these circumstances, the rate of statistical Type I errors is very high.  622 
Suggestions for Methodological Approaches to Investigate Synaptopathy in Humans 623 
With the current state of technology, synaptopathy is a pathology that can only reliably be revealed 624 
using histological techniques post-mortem. Because across-study differences in results may be due 625 
to methodological differences, researchers around the world are working to identify the “best” 626 
(most sensitive) non-invasive measures for detecting synaptopathy in humans.  Ultimately, a test 627 
battery should be sensitive to synaptopathy both when auditory thresholds are normal, as well as 628 
when other auditory deficits are present. However, given that most studies of synaptopathy in 629 
humans have used samples with clinically normal or near normal hearing thresholds, it is difficult 630 
to recommend the best test measures for diagnosing synaptopathy in individuals with abnormal 631 
auditory thresholds. Therefore, the following recommendations are oriented towards diagnosis of 632 
synaptopathy in people with normal audiograms. Many of the essential components of the test 633 
battery may be necessary in order to have confidence in inferences regarding synaptopathy. The 634 
recommendations are as follows: 635 
 636 
o Noise exposure measurement tools: At this time, a variety of retrospective self-report tools are 637 
being used to investigate noise-induced synaptopathy. Some are survey based and emphasize 638 
the past year; others are interview based and emphasize lifetime noise exposure history. The 639 
strongest approach would include prospective monitoring of changes in the auditory measures 640 
described below as a function of noise exposure documented via dosimetry, but such data will 641 
be difficult to collect over an individual’s lifetime. The more practical goal should be the 642 
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development of standardized survey tools that can be used across laboratories, although these 643 
are inevitably subject to recall bias. An alternative approach is the recruitment of subjects with 644 
specific risk factors (e.g. frequent exposure to very high-intensity amplified music, exposure to 645 
firearm discharge, work in a high-level noise environment) with planned comparisons with 646 
lower-exposure control subjects matched for age and sex. 647 
o Otoscopy: inspection of the ear canals is necessary to exclude participants with potential 648 
obstruction of the ear canal or other pathology that may confound the results. 649 
o Tympanometry: measurement of ear drum mobility while the pressure in the sealed ear canal is 650 
systematically changed; this is necessary to document a correctly functioning middle ear system. 651 
o Distortion product otoacoustic emissions (DPOAEs): a measure of OHC function, necessary for 652 
differential allocation of deficits to OHC or AN damage. Note that if sound conduction through 653 
the middle ear is compromised, DPOAEs will be reduced or absent even if the OHC population 654 
and function are intact. 655 
o During screening tests, DPOAEs are often scored as pass/fail based on whether their 656 
levels are at least 6 dB above the noise floor. This is inadequate and more stringent 657 
criteria should be used to guarantee normal OHC function.    658 
o When DPOAEs are used diagnostically, they are more commonly defined as present 659 
and normal, present but abnormal, or absent, with present but abnormal used to 660 
identify DPOAE responses that are present but at a reduced amplitude.  Empirical 661 
research is necessary to identify whether use of these three categories has adequate 662 
specificity and sensitivity for sorting participants in these studies.  663 
o DPOAE testing with f1 and f2 primary tone levels of 65 dB SPL and 55 dB SPL are 664 
common. A DP-gram obtained at these stimulus levels can be compared to 665 
normative values (Gorga et al. 1997, Table A1). Restricting study participation to 666 
individuals with DPOAE levels above the 95th percentile for Gorga et al.’s impaired 667 
sample will greatly limit OHC dysfunction. However, in noise-exposed samples, 668 
this may make it difficult to meet recruitment targets. 669 
o Testing at lower SPLs should also be considered; noise-induced deficits may 670 
emerge at lower SPLs prior to higher SPLs and thus subtle changes in OHC function 671 
can be missed. 672 
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o As the availability of clinical equipment capable of measuring high-frequency 673 
DPOAEs continues to improve, the ability to adjust for OAE amplitude may 674 
continue to improve, and it may be advisable to require “normal” OAEs of all study 675 
participants at all tested frequencies (Bramhall et al. 2017). Although inclusion of 676 
OAEs might improve the ability to interpret study outcomes, it must also be 677 
remembered that normal DPOAEs can be recorded even in the presence of OHC 678 
damage and thus normal DPOAEs do not necessarily imply the OHC population is 679 
not damaged (Subramaniam et al. 1994a; Subramaniam et al. 1994b; Chen & 680 
Fechter 2003). In addition, OAEs are not sensitive to IHC function, and therefore 681 
controlling for OAEs will not guarantee perfect matching between groups. 682 
 683 
o Pure-tone air conduction thresholds, including EHF assessment: Conventional threshold 684 
assessment is necessary, including 3 and 6 kHz, and it is essential that EHF assessment be 685 
completed up to 12-16 kHz. Multiple studies have provided evidence of deficits in the high 686 
frequency range related to noise exposure history, with or without corresponding changes in 687 
ABR wave I amplitude. As described earlier, ABR wave I is sensitive to basal cochlear function, 688 
so it may be important to control for EHF thresholds when making comparisons between 689 
participants using this metric.  690 
o ABR: a measure of the sound evoked neural response, evoked by tones or clicks. Protocols vary 691 
significantly across laboratories; in the absence of more sensitive metrics, this is the current gold 692 
standard in animal models and should be included in human studies. 693 
o Clicks will activate larger regions of the cochlea than tones; some laboratories 694 
record responses to both clicks and tones while others only report responses to 695 
clicks. In order to reduce the potential impact of OHC loss in subjects with EHF 696 
hearing loss, low-pass filtered clicks could be used. At high intensities, ANFs at 697 
high CFs will only contribute through their tails, which are not affected by OHC 698 
loss. To facilitate comparisons across studies, clicks should be included in all 699 
investigations, and tones, chirps, and other shaped signals should be considered as 700 
optional additions.  Because the original data from Kujawa and Liberman (2009) 701 
reveal frequency specific effects with both more cochlear synaptopathy in basal 702 
regions and greater wave I deficits at higher frequencies, it is reasonable to predict 703 
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that non-click signals may provide insight into patterns of damage within the human 704 
cochlea but we do not yet have sufficient evidence to recommend specific protocols. 705 
If data emerge documenting increased sensitivity with non-click signals, these 706 
recommendations should be re-evaluated. 707 
o In general, click levels vary from as low as 70 dB nHL to as high as 100 dB nHL. 708 
Some groups report these stimulus levels in dB nHL, while others report them in 709 
dB peSPL.  To facilitate comparisons across studies, both dB nHL and dB peSPL 710 
should be included in all reports.  Based on both animal data and the studies 711 
reporting ABR wave I deficits consistent with synaptopathy, 90 and 100 dB peSPL 712 
stimuli are likely to be the most sensitive in revealing wave I deficits; at least one 713 
of these higher-level conditions should be included. 714 
o Most human studies consider click durations of 80-100 µs (see Table I) to 715 
characterize the onset response of the population of AN fibers. It should be noted 716 
that adopting longer duration click or tone-burst stimuli with different windowing 717 
properties are known to alter the frequency-dependent sources which contribute to 718 
the ABR amplitude (Rasetshwane et al. 2013). The exact stimulus specifics for the 719 
ABR might thus also have an impact on their sensitivity to synaptopathy and/or on 720 
the AN fibers types which contribute to the population response.  721 
o Responses may be measured using dermal electrodes or ear canal electrodes; ear 722 
canal electrodes are increasingly used in more recent studies to improve resolution 723 
of wave I.  724 
o Overall configuration for recordings may be one-channel or two-channel 725 
configurations. In a one-channel configuration, the active electrode is placed at the 726 
high forehead (Cz or Fpz), the reference electrode is placed at the ipsilateral earlobe 727 
or the mastoid, and the ground is placed at the contralateral earlobe or mastoid. In a 728 
two-channel configuration, the active electrodes for both channels are placed on the 729 
high forehead (Cz or Fpz), reference electrodes are placed on both earlobes or both 730 
mastoids, and the ground is placed at the center of the forehead.  731 
o The number of samples averaged has ranged from 500 (Grinn et al. 2017) to 12,500 732 
(Valderrama et al. 2018). Increasing the number of samples averaged will reduce 733 
noise in the ABR waveform, making it easier to resolve wave I, but data collection 734 
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time is increased. It has been indicated that there is little improvement between 1000 735 
and 2000 averages, except near threshold where as many as 4000 averages may be 736 
needed (Hall 1992). It appears that 1000 averages is probably adequate when 737 
measuring responses to high level (90-100 dB SPL) click signals in a normal-738 
hearing population, but increased averaging may be required when including 739 
participants with abnormal pure tone thresholds. A conservative approach would be 740 
to average a minimum of 4000 responses; additional data would be helpful in 741 
guiding the minimum protocol requirements.    742 
o Increasing the stimulus rate reduces neural recovery time between stimuli, reduces 743 
the ability to resolve wave I, and increases wave V latency. Stimulus presentation 744 
rates vary widely across studies. Hall (1992) shows that wave I amplitude is constant 745 
up to 21/sec rates and the amplitude decreases at 31/sec and at higher rates. Thus, a 746 
21/sec rate would be recommended for a standard test rate; additional stimulus rates 747 
can be included to probe the rate of wave I amplitude decrease as stimulus rate 748 
increases.  749 
o Although ABR measurements are a necessary element of the test battery, it must be 750 
noted that the field is not yet at a point where it is feasible to agree on whether wave 751 
I amplitude is the best metric or not, with some data suggesting that wave I is 752 
insensitive to low-SR fiber loss (Bourien et al. 2014).  753 
Wave I has good test-retest reliability (low measurement error) but large between-subject 754 
variance (Mitchell et al. 1989; Don et al. 1994; Prendergast et al. 2018). A differential measure 755 
that reduces between-subject variance due to factors unrelated to synaptopathy is recommended 756 
for improved sensitivity. As discussed above, the use of a ratio derived from wave I (i.e., wave 757 
V/I, or SP/AP amplitude) or other metrics such as wave V latency may be problematic because 758 
(1) the value of the ratio critically depends on changes in the denominator and (2) wave V 759 
features reflect response characteristics from central auditory nuclei, which may or may not 760 
correlate with synaptopathy. The growth of ABR wave I with increasing stimulus intensity may 761 
be a useful differential wave I measure with reasonable test-retest reliability (Johannesen et al. 762 




o In the absence of OHC deficits, it is not clear whether ABR latencies are impacted 765 
by synaptopathy. Delayed and temporally-smeared first-spike latencies of LSR 766 
fibers compared to HSR fibers, make that the ABR wave-I is mostly dominated by 767 
the temporally precise HSR fibers (Bourien et al., 2014). A selective loss of LSR 768 
fibers or different degrees of HSR fiber loss is thus not expected to impact the ABR 769 
wave-I latency much (see also simulations in Verhulst et al., 2018a). However, there 770 
is a suggestion that the degree to which the ABR wave-V latency shifts when 771 
background noise is added can be a marker of selective low/medium-SR fiber loss 772 
(Mehraei et al. 2016). In contrast to suggestions that ABR latencies reflect cochlear 773 
synaptopathy, it must also be noted that ABR latencies are very sensitive to OHC 774 
deficits and the shape of the audiogram (Gorga et al. 1985; Lewis et al. 2015). This 775 
means that ABR latencies for constant SPL stimulation can be used as a control 776 
measure to verify whether EHF loss contributed to the degraded ABR wave I 777 
amplitude. Specifically, the ABR waves would be delayed in listeners with OHC 778 
loss, when compared to listeners without OHC loss but with or without 779 
synaptopathy. 780 
o It is important to control for any potential confounds due to high-frequency hair cell 781 
damage, which may impact wave I in particular (and more so than wave V given 782 
that wave-V generators are more low-frequent than the wave-I generators (Don and 783 
Eggermont, 1978)).  EHF testing and/or high-frequency DPOAE measurements 784 
provide critical insight into peripheral damage and one or both of these measures 785 
should be included. Even in a sample with normal audiograms, it is advisable that 786 
ABR measures are statistically adjusted for between-subject differences in OAEs. 787 
OAEs are more sensitive to noise exposure than pure tone thresholds (Engdahl & 788 
Kemp 1996; Seixas et al. 2005; Marshall et al. 2009) and OAEs measured in the 789 
high frequencies (4-8 kHz) are correlated with pure tone thresholds in the extended 790 
high frequencies (11-20 kHz, Arnold et al. 1999). Given that OAEs are reflective of 791 
peripheral auditory function, adjusting ABR wave I amplitudes for OAEs may be 792 
preferable to adjusting for pure tone thresholds, which theoretically could be 793 
impacted by high levels of neuronal loss. Another potential method of limiting the 794 
impact of high frequency hair cell damage is to add notched noise to the ABR 795 
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stimulus. It should also be noted that wave I can be impacted by sub-clinical IHC 796 
dysfunction, and distinguishing synaptopathy from IHC dysfunction is problematic 797 
using wave I amplitude in isolation. It will also be problematic to distinguish 798 
synaptopathy (loss of synapses) from deafferentation (loss of nerve fibers) using 799 
wave I.  In the absence of histopathology, which cannot be collected from live 800 
participants, we recommend that authors reporting results remain cognizant of these 801 
limitations and specifically acknowledge the imprecision of wave I results. 802 
 803 
In summary, it is reasonable to infer there is a pathology of the IHCs, the synapses, or the ascending 804 
neural pathway, if middle ear conduction, OHC function, and threshold sensitivity (including EHF 805 
thresholds) are all normal, but there is decreased amplitude of the AP or wave I of the ABR. If 806 
middle ear conduction, OHC function, or threshold sensitivity is suspected to be compromised, the 807 
inference of selective synaptopathy is drawn into question. This does not mean synaptopathy has 808 
not occurred, but that functional deficits and/or supra-threshold complaints cannot be attributed to 809 
a selective neural pathology as there are other potentially contributing pathologies present.  810 
 811 
There are a number of optional (experimental) elements of the test battery that labs may consider 812 
adding; it is possible that one or more of these elements will ultimately be identified as essential 813 
components to include in future investigations. These are described below. 814 
 815 
• Middle ear muscle reflex (MEMR): also termed the acoustic reflex, stapedius reflex, or auditory 816 
reflex; this is an involuntary muscle contraction which can be triggered by either ipsilateral or 817 
contralateral sound. The AN must be intact to initiate the acoustic reflex; the strength of the 818 
acoustic reflex is reduced in mice with synaptopathy (Valero et al. 2016; Valero et al. 2018) 819 
and this may prove to be a useful metric in humans as well. MEMRs are known to be weak, or 820 
absent, in a subset of the population (Flamme et al. 2017; McGregor et al. 2018), and it has 821 
been suggested that synaptopathic injury could underlie this observed individual variability 822 
(Wojtczak et al. 2017). Use of a wideband probe and a broadband activator stimulus has been 823 
shown to lower MEMR thresholds compared to the standard 226 Hz probe tone used clinically, 824 
which could perhaps improve the ability to reliably detect MEMR responses in future studies 825 
(Feeney et al. 2017). 826 
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• Signal-in-Noise/Speech-in-Noise testing: Various labs are using different clinical tests, 827 
including the QuickSin, WIN, Matrix test, and others. The custom manipulation of the NU-6 828 
words by Liberman et al. (2016) revealed significant differences in performance for high risk 829 
and low risk participants. However, this test is not readily available to others, complicating 830 
replication of the testing and reproduction of the results by other laboratories. Furthermore, 831 
task difficulty can be defined simply in terms of percent correct performance, which is easily 832 
manipulated in any speech-in-noise test by changing the signal-to-noise ratio. Making a test 833 
more “complex” with respect to the cues available would be expected to make the test more 834 
cognitively demanding (for example, requiring increased attention and listening effort). This is 835 
likely to make performance more reliant on central rather than peripheral factors, reducing 836 
sensitivity to synaptopathy. 837 
• Testing audiometric thresholds for brief tones (<20ms) has been suggested as a possible method 838 
for detecting synaptopathy. Theoretical reasoning by Lopez-Poveda and Barrios (2013) and 839 
perceptual model simulations by Marmel et al. (2015) suggest that synaptopathy involves a 840 
substantial loss of low-threshold AN fibers in addition to the larger loss of high-threshold 841 
fibers, which is predicted to elevate the detection threshold for brief tones, without significantly 842 
elevating the thresholds for longer sounds. The results of Wong et al. (2019) in the budgerigar 843 
undermine this approach and the experimental data currently available are not adequate to allow 844 
a recommended protocol for this test. 845 
• Supra-threshold temporal tasks: Basic psychoacoustic tasks such as amplitude-modulation 846 
detection, temporal fine-structure sensitivity tasks, tone-in-noise detection, frequency and 847 
intensity discrimination as well as basic binaural ITD or ILD sensitivity tasks have been 848 
completed by some laboratories, but there is only limited theoretical development relating 849 
synaptopathy to specific deficits of interest. In those cases where deficits are present on only a 850 
subset of temporal processing tasks, interpretation is challenging. Some of these tests will be 851 
compromised by OHC pathology, highlighting the need for careful DPOAE assessment, if 852 
deficits are to be attributed to selective neural injury.  853 
Hyperacusis tools: There are no uniform measures of hyperacusis; loudness discomfort levels 854 
could be considered for inclusion (following Bramhall et al. 2018), although this measure may 855 
not be a good predictor of hyperacusis. Alternatively, a measure of loudness growth, such as the 856 
Contour Test of Loudness Perception (Cox et al. 1997), or categorical loudness scaling (Brand & 857 
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Hohmann 2002), might be a better metric. Annoyance related to everyday sounds and avoidance 858 
of noisy environments (following Liberman et al 2016) could be considered for inclusion as well.  859 
• ABR amplitude versus latency plots can be derived from the raw data and may be considered 860 
as per Verhulst et al. (2016) to further disentangle the contribution of OHC and synaptopathy 861 
aspects to SNHL. 862 
• Envelope following response (EFR): The EFR is a steady-state sound evoked response which 863 
follows the envelope of an AM stimulus. The carrier and modulation frequency can be 864 
manipulated, as well as the depth of amplitude modulation. Some studies have also included 865 
masking noise (e.g., Bharadwaj et al. 2015; Paul et al. 2017). However, as described above, the 866 
EFR cannot be measured in humans easily at the high modulations rates (~1 kHz) that are 867 
associated with synaptopathy in animal models. Even though model simulations suggest that 868 
EFRs to lower modulation rates may also be sensitive to synaptopathy, the interpretation of the 869 
EFR metric in terms of synaptopathy might depend critically on the stimulus characteristics 870 
and masking noise applied.  871 
Ultimately, to reach a definitive differential diagnosis of synaptopathy, we may need to turn to 872 
novel brain imaging techniques, perhaps variations of magnetic resonance imaging (MRI), positron 873 
emission tomography (PET) or magnetoencephalography (MEG), or some future technique not yet 874 
developed. For example, a new molecular imaging technique to detect changes in the 875 
neurotransmitter dopamine in the human brain has been described by Badgaiyan (2014). It may be 876 
that research efforts into other neurological conditions, such as Alzheimer’s disease, may yield 877 
viable techniques which hearing scientists can adopt for the detection of abnormal synaptic 878 
transmission at the AN. 879 
 880 
The above list of suggestions for assays to detect synaptopathy is quite lengthy and would not be 881 
clinically feasible for diagnostic purposes due to time constraints. However, at this point in time it 882 
is not possible to minimize the number of assays because of the many uncertainties within the 883 
literature. A more concise battery of assays can only be suggested when the number of studies 884 





Despite a concerted international research effort over the past several years, conclusive evidence 888 
for noise-induced cochlear synaptopathy in humans remains elusive. In this commentary, we have 889 
discussed some of the possible reasons behind this. We have described how each of the various 890 
experimental approaches, including electrophysiological, questionnaire and behavioural measures 891 
have proved to be imperfect metrics. Although there may be techniques we can use to control 892 
variability, improve robustness, and increase statistical power, we seem far from reaching a 893 
satisfactory diagnostic approach. There are also important questions to be answered about the 894 
extent to which human synaptopathy mirrors the animal models, particularly in relation to the 895 
intensity of noise that is needed to induce synaptic damage in humans, the relative susceptibility of 896 
low-, medium- and high-SR fibers, and the possibility that structural repair at the synapse may 897 
occur following early auditory insults. Given that aging and cumulative noise exposure are 898 
necessarily correlated and associated with peripheral and central damage in addition to 899 
synaptopathy, disentangling noise-induced synaptopathy from deterioration of other auditory 900 
structures may prove to be an insurmountable challenge. Nevertheless, it is important to continue 901 
our efforts to determine whether synaptopathy occurs in humans, and to better understand its 902 
potential perceptual effects. As one of several peripheral and central factors that may contribute to 903 
suprathreshold hearing deficits in humans, we need to be able to characterize its relative influence 904 
on an individual’s overall auditory function. Understanding these relationships is essential if we 905 
are to move beyond the audiogram towards a holistic model of person-specific hearing care that 906 
diagnoses and treats both the “hidden” and “unhidden” components that underlie human hearing 907 
impairment.  908 
 909 
 910 
Figure Legends 911 
Figure 1.  912 
Histological evidence of synaptopathy in human temporal bones. Figure shows analysis of 913 
orphan ribbons in the IHC area. A: Thumbnail re-projections of the voxel space immediately 914 
surrounding 12 selected synaptic ribbons from z-stacks. Some ribbons are clearly juxtaposed to 915 
nerve terminals (left two columns) while others are not (right column). Only the red (anti-CtBP2) 916 
and green (anti-neurofilament) channels are shown for clarity. B: Percentage of orphan ribbons, 917 
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i.e. those not closely juxtaposed to post-synaptic terminals, as assessed by evaluating thumbnail 918 
arrays such as those illustrated in A, for each of the five completely reconstructed ears in the 919 
present study. Reprinted with permission from Viana et al., 2015, Hearing Research.  920 
 921 
Figure 2. Evidence of noise exposure-related ABR wave I amplitude reduction in humans. 922 
Mean ABR waveforms and peak amplitudes are plotted by noise exposure group. ABR wave I 923 
amplitude was reduced in the Veteran High Noise and non-Veteran Firearms groups compared 924 
with the non-Veteran control and Veteran Low Noise groups, while waves III and V were similar 925 
across groups. A: Waveforms were generated in response to a 110 dB p-pe SPL 4 kHz toneburst 926 
and averaged across all participants in each group. The peaks of waves I, III, and V are labeled. 927 
The inset shows the average wave V peak after correcting for variability in peak latency across 928 
participants. B: Wave amplitudes were measured from responses to a 110 dB p-pe SPL 4 kHz 929 
toneburst and then averaged across groups. Wave I and III amplitudes were measured as the 930 
difference in voltage between the wave peak and the following trough. Due to difficulty 931 
identifying the wave V trough in some participants, wave V amplitude was measured as the 932 
voltage difference between the wave V peak and the prestimulus baseline (average voltage 933 
measured for the 1-msec period of time before the stimulus presentation). Error bars indicate the 934 
standard error of the mean. ABR indicates auditory brainstem response. Reprinted with 935 
permission from Bramhall NF, Konrad-Martin D, McMillan GP, Griest SE. Auditory Brainstem 936 
Response Altered in Humans With Noise Exposure Despite Normal Outer Hair Cell Function. 937 
Ear Hear. 2017 Jan/Feb;38(1):e1-e12. https://insights.ovid.com/pubmed?pmid=27992391 938 
 939 
Figure 3. Evidence of noise-exposure related increase in SP/AP ratio in humans. 940 
Electrocochleography shows evidence for cochlear synaptopathy in the high-risk group. A: 941 
Averaged waveforms (±SEMs) from each group in response to clicks delivered at 9.1 Hz in 942 
alternating polarity at 94.5 dB nHL. SP and AP are measured from baseline to peak, as 943 
illustrated. B: Increasing click rate from 9.1 Hz to 40.1 Hz decreases AP without affecting SP: 944 
mean waveforms from 6 subjects are shown. C: Mean SP/AP ratio is nearly twice as high in the 945 
high-risk vs. the low-risk group. This difference remains when subjects are separated by sex. D: 946 
The difference in SP/AP ratios arises from both an increase in the SP and a decrease in the mean 947 
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AP, although only the SP differences are statistically significant. All data are means (±SEM). 948 
***p<0.001; **p<0.01. From Liberman et al., 2016. 949 
 950 
Figure 4. Evidence that self-reported noise exposure is not correlated with ABR wave I 951 
amplitude in humans.The relationship between self-reported noise exposure (calculated as 952 
LAeq8760) and action potential (AP) amplitude is shown for male and female participants for 953 
stimuli including A: clicks, B: 2 kHz tone bursts, C: 3 kHz tone bursts, and D: 4 kHz tone bursts. 954 
All AP amplitude data were normally distributed. Pearson correlation analysis revealed no 955 
statistically significant relationships between self-reported noise history and AP amplitude within 956 
males or females. Lines of best fit are shown (Males: black symbols and regression lines; 957 
Females: red symbols and regression lines). From Grinn et al., 2017.  958 
 959 
Figure 5. Evidence that ABR wave I amplitude is not decreased by noise exposure in 960 
humans. 961 
Grand average ABR waveforms. Average waveforms are shown in microvolts for males and 962 
females separately and for the 15 lowest and 15 highest noise exposed individuals for each sex. 963 
Waves I, III and V can be seen at around 2, 4 and 6 ms respectively. Waveforms are plotted 964 
broadband in order to show the full morphology of the response. Reprinted with permission from 965 
Prendergast et al., 2017. Hearing Research.  966 
 967 
Figure 6. Evidence that ABR wave I amplitude is not decreased among individuals with 968 
problems understanding speech in noise. 969 
ABRs elicited by 102 dB peSPL clicks for verified-SPiN-impairment and control groups. A: 970 
Grand average waveforms (averaged across ears and across participants). Shaded areas represent 971 
the SEM. B: Wave I and wave V amplitudes, presented as mean ± SEM. Reprinted with 972 
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